Vector Science and Therapeutics Corp.
PAIN.V
TSX
| 02/28/2026 | |||||
|---|---|---|---|---|---|
| Net Income | 75.59% | ||||
| Total Depreciation and Amortization | 26.92% | ||||
| Total Amortization of Deferred Charges | -- | ||||
| Total Other Non-Cash Items | -207.57% | ||||
| Change in Net Operating Assets | -1,150.50% | ||||
| Cash from Operations | -38.36% | ||||
| Capital Expenditure | 97.95% | ||||
| Sale of Property, Plant, and Equipment | -- | ||||
| Cash Acquisitions | -- | ||||
| Divestitures | -- | ||||
| Other Investing Activities | 90.14% | ||||
| Cash from Investing | 96.82% | ||||
| Total Debt Issued | -125.00% | ||||
| Total Debt Repaid | -- | ||||
| Issuance of Common Stock | -- | ||||
| Repurchase of Common Stock | -- | ||||
| Issuance of Preferred Stock | -- | ||||
| Repurchase of Preferred Stock | -- | ||||
| Total Dividends Paid | -- | ||||
| Other Financing Activities | 100.00% | ||||
| Cash from Financing | -134.26% | ||||
| Foreign Exchange rate Adjustments | -- | ||||
| Miscellaneous Cash Flow Adjustments | -- | ||||
| Net Change in Cash | -43.38% | ||||